Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1260321.RAX8CCrfd6h_00pU-xBsLIRvPnTc5Rnsgd6men3Wy1U_w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1260321.RAX8CCrfd6h_00pU-xBsLIRvPnTc5Rnsgd6men3Wy1U_w130_assertion type Assertion NP1260321.RAX8CCrfd6h_00pU-xBsLIRvPnTc5Rnsgd6men3Wy1U_w130_head.
- NP1260321.RAX8CCrfd6h_00pU-xBsLIRvPnTc5Rnsgd6men3Wy1U_w130_assertion description "[The expression level of miR-29b-2, -155, -197 and -205 was significantly increased in the serum of breast cancer patients. miR-29b-2, -155, -197 and -205 may be useful as a blood-based biomarker for breast cancer screening.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1260321.RAX8CCrfd6h_00pU-xBsLIRvPnTc5Rnsgd6men3Wy1U_w130_provenance.
- NP1260321.RAX8CCrfd6h_00pU-xBsLIRvPnTc5Rnsgd6men3Wy1U_w130_assertion evidence source_evidence_literature NP1260321.RAX8CCrfd6h_00pU-xBsLIRvPnTc5Rnsgd6men3Wy1U_w130_provenance.
- NP1260321.RAX8CCrfd6h_00pU-xBsLIRvPnTc5Rnsgd6men3Wy1U_w130_assertion SIO_000772 25644077 NP1260321.RAX8CCrfd6h_00pU-xBsLIRvPnTc5Rnsgd6men3Wy1U_w130_provenance.
- NP1260321.RAX8CCrfd6h_00pU-xBsLIRvPnTc5Rnsgd6men3Wy1U_w130_assertion wasDerivedFrom befree-2016 NP1260321.RAX8CCrfd6h_00pU-xBsLIRvPnTc5Rnsgd6men3Wy1U_w130_provenance.
- NP1260321.RAX8CCrfd6h_00pU-xBsLIRvPnTc5Rnsgd6men3Wy1U_w130_assertion wasGeneratedBy ECO_0000203 NP1260321.RAX8CCrfd6h_00pU-xBsLIRvPnTc5Rnsgd6men3Wy1U_w130_provenance.